Search Results 821-830 of 37919 for Two-phase
Additionally patients with hematologic malignancies will be evaluated on a treatment schedule of five days in a row with two weeks off. Participation ...
Some breast cancer cells make too much of a protein called human epithelial growth factor-receptor 2, also called HER2. Healthy breast cells make some HER2 ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 for ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this ... In Part 2, the step-up dose identified in Part 1 will be used followed by ...
... Phase 1b, and to evaluate the effectiveness of TAK-981 in combination with rituximab in r/r CD20+ NHL in Phase 2. Participation eligibility. Participant ...
The purpose of this trial is to determine the maximum tolerated dose (MTD)/recommended Phase 2 dose for NXP800. Participation eligibility. Participant ...
Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
Phase 2: The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative to the control arm in adult patients hospitalized ...
The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study will ...
Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.